This Article Full Text (PDF) All Versions of this Article: 1352458508093616v1 14/8/1056    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hirotani, M Articles by Sasaki, H Search for Related Content PubMed PubMed Citation Articles by Hirotani, M Articles by Sasaki, H Social Bookmarking                         What's this?

Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients

Department of Neurology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan;

C Maita

Graduate School of Agriculture, Hokkaido University, Sapporo, Japan;

M Niino

Department of Neurology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan niino{at}med.hokudai.ac.jp

SM Iguchi-Ariga

Graduate School of Agriculture, Hokkaido University, Sapporo, Japan

S Hamada

Hokuyukai Neurological Hospital, Sapporo, Japan

H Ariga

Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

H Sasaki

Department of Neurology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

Objectives

DJ-1 plays a key role in the anti-oxidative stress function. Increasing evidence supports the role of oxidative stress in the pathogenesis of multiple sclerosis (MS). The aim of this study was to investigate whether the DJ-1 levels were increased in patients with MS and to examine its association with the progression of MS.

Methods

Quantitative immunoblot assays were performed to evaluate the DJ-1 level in serum and cerebrospinal fluid (CSF) collected from relapsing–remitting patients with MS (n = 29), disease controls subjects (n = 14), and healthy subjects (n = 44).

Results

No significant difference was observed in the serum DJ-1 level among the patients with MS, disease controls, and healthy controls. However, the CSF DJ-1 levels were significantly higher in the patients with MS than in the disease control subjects (P < 0.0001). A significant positive correlation was also found between the CSF DJ-1 levels and the Multiple Sclerosis Severity Score (P < 0.005, r = 0.501).

Conclusions

These results show that the CSF DJ-1 levels are significantly increased in the CSF of patients with MS and that the CSF DJ-1 levels may be associated with the disease progression of MS. Therefore, DJ-1 possibly plays an important role in the pathogenesis of MS.

Key Words: cerebrospinal fluids • DJ-1 • multiple sclerosis • multiple sclerosis severity score • neurodegenerative process • oxidative stress

This version was published on September 1, 2008

Multiple Sclerosis, Vol. 14, No. 8, 1056-1060 (2008)
DOI: 10.1177/1352458508093616


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?